Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae.

Thomas SR, Leung S, Knox K, Wilkinson TMA, Staples KJ, Lestrate P, Wauters D, Gorringe A, Taylor SC.

BMC Microbiol. 2018 Oct 29;18(1):167. doi: 10.1186/s12866-018-1314-5.


Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.

Levy J, Licini L, Haelterman E, Moris P, Lestrate P, Damaso S, Van Belle P, Boutriau D.

Hum Vaccin Immunother. 2015;11(3):620-31. doi: 10.1080/21645515.2015.1011021.


Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Berglund J, Vink P, Tavares Da Silva F, Lestrate P, Boutriau D.

Clin Vaccine Immunol. 2014 Jan;21(1):56-65. doi: 10.1128/CVI.00430-13. Epub 2013 Oct 30.


One or two doses of quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine is immunogenic in 9- to 12-month-old children.

Klein NP, Baine Y, Bianco V, Lestrate PR, Naz A, Blatter M, Friedland LR, Miller JM.

Pediatr Infect Dis J. 2013 Jul;32(7):760-7. doi: 10.1097/INF.0b013e31828693c5.


Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.

Bryant KA, Marshall GS, Marchant CD, Pavia-Ruiz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Lestrate P, Boutriau D, Friedland LR, Miller JM.

Pediatrics. 2011 Jun;127(6):e1375-85. doi: 10.1542/peds.2009-2992. Epub 2011 May 29.


Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.

Poolman JT, De Vleeschauwer I, Durant N, Devos N, Feron C, Lestrate P, Weynants V, Boutriau D.

Clin Vaccine Immunol. 2011 Jul;18(7):1108-17. doi: 10.1128/CVI.00549-10. Epub 2011 May 18.


Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.

Poolman JT, Frasch CE, Käyhty H, Lestrate P, Madhi SA, Henckaerts I.

Clin Vaccine Immunol. 2010 Jan;17(1):134-42. doi: 10.1128/CVI.00289-09. Epub 2009 Nov 4.


Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.

Toropainen M, Raitolehto A, Henckaerts I, Wauters D, Poolman J, Lestrate P, Käyhty H.

Infect Immun. 2008 Oct;76(10):4546-53. doi: 10.1128/IAI.00418-08. Epub 2008 Jul 21.


Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulence.

Haine V, Sinon A, Van Steen F, Rousseau S, Dozot M, Lestrate P, Lambert C, Letesson JJ, De Bolle X.

Infect Immun. 2005 Sep;73(9):5578-86.


The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection.

Fretin D, Fauconnier A, Köhler S, Halling S, Léonard S, Nijskens C, Ferooz J, Lestrate P, Delrue RM, Danese I, Vandenhaute J, Tibor A, DeBolle X, Letesson JJ.

Cell Microbiol. 2005 May;7(5):687-98.


The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.

Danese I, Haine V, Delrue RM, Tibor A, Lestrate P, Stevaux O, Mertens P, Paquet JY, Godfroid J, De Bolle X, Letesson JJ.

Infect Immun. 2004 Oct;72(10):5783-90.


Brucella pathogenesis, genes identified from random large-scale screens.

Delrue RM, Lestrate P, Tibor A, Letesson JJ, De Bolle X.

FEMS Microbiol Lett. 2004 Feb 9;231(1):1-12. Review.


Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice.

Lestrate P, Dricot A, Delrue RM, Lambert C, Martinelli V, De Bolle X, Letesson JJ, Tibor A.

Infect Immun. 2003 Dec;71(12):7053-60.


Fun stories about Brucella: the "furtive nasty bug".

Letesson JJ, Lestrate P, Delrue RM, Danese I, Bellefontaine F, Fretin D, Taminiau B, Tibor A, Dricot A, Deschamps C, Haine V, Leonard S, Laurent T, Mertens P, Vandenhaute J, De Bolle X.

Vet Microbiol. 2002 Dec 20;90(1-4):317-28. Review.


Identification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensis.

Taminiau B, Daykin M, Swift S, Boschiroli ML, Tibor A, Lestrate P, De Bolle X, O'Callaghan D, Williams P, Letesson JJ.

Infect Immun. 2002 Jun;70(6):3004-11.


Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.

Al-Mariri A, Tibor A, Lestrate P, Mertens P, De Bolle X, Letesson JJ.

Infect Immun. 2002 Apr;70(4):1915-23.


Identification of Brucella spp. genes involved in intracellular trafficking.

Delrue RM, Martinez-Lorenzo M, Lestrate P, Danese I, Bielarz V, Mertens P, De Bolle X, Tibor A, Gorvel JP, Letesson JJ.

Cell Microbiol. 2001 Jul;3(7):487-97.


Identification and characterization of in vivo attenuated mutants of Brucella melitensis.

Lestrate P, Delrue RM, Danese I, Didembourg C, Taminiau B, Mertens P, De Bolle X, Tibor A, Tang CM, Letesson JJ.

Mol Microbiol. 2000 Nov;38(3):543-51.

Supplemental Content

Loading ...
Support Center